Dr. Thon is a serial biotech entrepreneur, accomplished CEO, and experienced Board Member/Advisor with technical expertise in cell & gene therapy, hematology, cell culture/manufacturing, and delivery, who specializes in founding and leading startups through company formation, discovery, and pre/clinical development. Jonathan has a successful track record of raising Seed and Series A funding in aggregate of $160M from venture capital, strategic and private investors, and non-dilutive sources including the Bill and Melinda Gates Foundation, the Department of Defense, the National Institutes of Health, ARPA-H, and BARDA. He has demonstrated strategic and operational leadership ability in defining, communicating, and scaling ambitious technical visions for innovative, high-growth startups.

Jonathan is a seasoned inspirational executive who excels at securing new financing, IP creation, and building high performance management teams and collaborative research environments.